Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
PASC Post Acute Sequelae of COVID 19: early-phase trial registry
4 of 7 indexed PASC Post Acute Sequelae of COVID 19 trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
PASC Post Acute Sequelae of COVID 19: 7 US clinical trials tracked, 4 recruiting.
PASC Post Acute Sequelae of COVID 19 is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Bateman Horne Center, running 1 of these trials.
Enrollment posture brief
Registry condition pasc-post-acute-sequelae-of-covid-19
OPEN 4 | RECR 57% | LATE 0 | EARLY 3 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
PASC Post Acute Sequelae of COVID 19 lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for PASC Post Acute Sequelae of COVID 19 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
PASC Post Acute Sequelae of COVID 19 is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of PASC Post Acute Sequelae of COVID 19 trials is spread across many organizations.
Bateman Horne Center accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most PASC Post Acute Sequelae of COVID 19 trials plan to enrol fewer than 100 people.
Median target enrolment is 59 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
PASC Post Acute Sequelae of COVID 19 research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
Hugo W. Moser Research Institute at Kennedy Krieger
NCT07278388
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
University of New Mexi
NCT06940609
Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
University of California, Davis
NCT07076862
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
National Institute of Neurological Disorders and Stroke (NINDS)
NCT06577467
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
Massachusetts General Hospital
NCT05040659
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
University of California, Los Angeles
NCT06586398
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Bateman Horne Center
NCT06316843
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on PASC Post Acute Sequelae of COVID 19 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on PASC Post Acute Sequelae of COVID 19 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this PASC Post Acute Sequelae of COVID 19 page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 PASC Post Acute Sequelae of COVID 19 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Bateman Horne Center sponsors the most PASC Post Acute Sequelae of COVID 19 trials on record, review their full trial history before evaluating a specific study. See Bateman Horne Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PASC Post Acute Sequelae of COVID 19 condition card totals 7 registered trials; most-linked intervention Valacyclovir celecoxib dose 2; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.